By explicitly specifying treatment effects and intercurrent events, estimands help sponsors, clinicians, and regulators work from a shared understanding.
A new pilot under BioMed X’s XBridge framework aims to connect Harvard investigators with pharmaceutical researchers through structured matchmaking and sponsored research agreements.
QIAGEN Digital Insights bioinformatics bring over 25 years of expertise in expert-curated content, AI-powered proprietary algorithms and user-friendly tools to simplify NGS data analysis
Clinicians, researchers, and communicators are developing more effective strategies to disseminate information about clinical trials to reach a wider audience. They ultimately expect that this will lead to more inclusive trials.